Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007
Date:11/13/2007

3 30,997 35,590

General and

administrative 2,050 1,864 6,419 7,420

Total operating expenses 12,515 10,447 37,416 43,010

Loss from operations (4,929) (3,680) (10,356) (23,667)

Interest income (expense),

net 156 282 472 500

Net loss (4,773) (3,398) (9,884) (23,167)

Accretion to redemption

value of redeemable

convertible preferred stock - - - (49)

Net loss attributable to

common stockholders $(4,773) $(3,398) $(9,884) $(23,216)

Basic and diluted net loss

per share attributable to

common stockholders $(0.31) $(0.23) $(0.65) $(1.74)

Shares used to compute

basic and diluted net

loss per share

attributable to

common stockholders 15,392 15,048 15,318 13,323

Three Months Ended Three Months Ended

September 30, 2007 (1) September 30, 2006 (1)

Stock-based Reported Stock-based Reported

compensation GAAP compensation GAAP

non-GAAP expense results non-GAAP expense results

Net loss

attributable to

common

stockholders $(4,084) $(689) $(4,773) $(2,462) $(936) $(3,398)

Basic and

diluted net

loss per share

attributable

to common

stockholders $(0.27) $(0.04) $(0.31) $(0.16) $(0.06) $(0.23)

Research and

development

expenses $10,105 $360 $10,465 $8,222 $361 $8,583

General and

administrative

expenses $1,721 $329 $2,050 $1,289 $575 $1,864

Nine
'/>"/>

SOURCE SGX Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... A fortuitous collaboration at Rice University has led ... natural antibiotic. , The laboratory recreation of a ... the fight against bacteria that evolve resistance to ... , As part of the process, Rice ... Shamoo and their colleagues created and tested a ...
(Date:8/28/2014)... nerves with adhesives, most researchers place glue directly on ... the nerve ends well and allows glue to easily ... However, it is difficult to insert the nerve ends ... there is frictional resistance. Xiangdang Liang and co-workers from ... conduit for the adhesive technique and defined the best ...
(Date:8/28/2014)... can be treated with nasal septum cells. Researchers at ... that cells taken from the nasal septum are able ... and can thus repair articular cartilage defects. The nasal ... joint environment is associated with the expression of so-called ... has published the research results together with the ...
(Date:8/28/2014)... every 200 Ontarians has been diagnosed with inflammatory bowel ... the disease increasing by 64 per cent between 1999 ... the Institute for Clinical Evaluative Sciences (ICES), the Children,s ... Research Institute. That puts Ontario in the 90th percentile ... published this week in Inflammatory Bowel Diseases , ...
(Date:8/28/2014)... seven per cent of rheumatoid arthritis patients in the ... as anti-TNF therapies did not take them as prescribed ... Infirmary were among those from 60 hospitals around the ... Arthritis Research UK Centre for Genetics and Genomics at ... that failure to take the drugs correctly, known as ...
Breaking Medicine News(10 mins):Health News:Synthesis produces new antibiotic 2Health News:Synthesis produces new antibiotic 3Health News:Synthesis produces new antibiotic 4Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Ontario has one of the highest rates of IBD in the world 2Health News:Arthritis patients failing to take expensive medication, according to new research 2
... the malaria parasites to attack the red blood cells. ... Cell, will help the scientists in designing vaccines against ... through which malaria parasites invade red blood cells is ... merozoites called EBA-175 to a receptor protein on the ...
... a smart bomb for cancer treatment is to be reported ... into the tumor, seal the opening and then deliver ... This will leave the healthy cells unharmed. ,The ... cancer have the potential of being a revolutionary form of ...
... those people suffering from tension-headaches, acupuncture may be the ... journal BMJ said that acupuncture can reduce the incidence ... - the gold standard of clinical trials - researchers ... of tension headache into three groups. ,Over ...
... delays healing of physical wounds, a new study says//. ... of Illinois at Chicago in a study of laboratory ... delayed the closing of wounds by more than 45 ... of cell and genetic changes accounted for the slow ...
... and happen even when people are not aware of their ... 2005 issue of Nature. ,Researchers from University of California, ... Affairs Health System had undertaken the study to find out ... when they are actually not aware of doing so. ...
... A new study by scientists in Japan may help ... UPI. ,Richard Smith, a research professor in otolaryngology ... University gave a genetically deafened mouse interfering RNA (Ribonucleic ... that would otherwise cause deafness. ,"By preventing its ...
Cached Medicine News:Health News:Researchers Discover Protein That Causes Malaria 2Health News:An Anti-cancer Smart Bomb delivered using a Nanocell 2Health News:An Anti-cancer Smart Bomb delivered using a Nanocell 3Health News:Acupuncture May Be An Effective Treatment Against Tension-Headaches 2Health News:Habit Memory May Enhance Learning In People 2
(Date:8/28/2014)... 2014 According to a new ... (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) - ... 2014 - 2020" the global radiofrequency identification (RFID) market ... is expected to grow at a CAGR of 13.9% ... of USD 5.3 billion in 2020. Browse ...
(Date:8/28/2014)... PITTSBURGH , Aug. 28, 2014 /PRNewswire-iReach/ -- ... exhibiting at the 9 th Annual Global ... , September 8-9 th . The Global ... industry leaders in small molecule and biologic pharmaceutical ... address challenges that today,s manufacturers face, such as ...
(Date:8/28/2014)... , Aug. 28, 2014  Stryker Orthopaedics, the Official Joint ... bringing its message of joint health to golf fans at ... at the Deutsche Bank Championship. The company,s fan destination – ... Fan Zone on 9" at the TPC Boston in ... th .    At the Deutsche Bank Championship, ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
... 11 CEL-SCI Corporation (NYSE CVM), a ... for the prevention and treatment of infectious diseases, announced today ... manufacturing equipment at its GMP manufacturing facility in Maryland. Completion ... it allows CEL-SCI to move forward with its drug manufacturing ...
... ... , , , , BOTHELL, Wash., Jan. 11 ... in automated external defibrillator ( AED ) and diagnostic cardiac monitoring devices, has ... development and commercialization of simple, cost-effective medical products and services that positively impact ...
Cached Medicine Technology:CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 2CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 3CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 4Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine 2Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine 3Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine 4Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine 5Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine 6Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine 7
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
Medicine Products: